No results found for “”
No results found for filter “”
-
Blog articles 14.06.19
Rare & childhood diseases: addressing unmet need
With the right framework in place we can continue to work together to meet the needs of children and adults living with a rare disease. As an industry...
Read Article -
Blog articles 13.06.19
Can registries drive better outcomes for diabetes patients? (Guest blog)
A roundtable in Stockholm will explore the opportunities and barriers to diabetes registries
Read Article -
Blog articles 12.06.19
Cancer data: Are you ready to meet your DigiTwin? (Guest blog)
Predictive computer models will guide clinical decisions, helping clinicians choose the most effective prevention and treatment options for you
Read Article -
Statements & press releases 11.06.19
Road to Value Based Healthcare
A full-day seminar in Warsaw on the role of outcomes-measurement in delivering more for patients and improving the long-term sustainability of our health...
Read Article -
Blog articles 11.06.19
Making the connections that count: building bridges to the future
With the challenges facing healthcare in Europe I am pretty certain no one sector has all the answers. It is vital that we come together to explore the...
Read Article -
Blog articles 06.06.19
Rethinking access to medicines in Lithuania (Guest blog)
Lithuania is on the cusp of a major overhaul of its Health Technology Assessment (HTA) system. The changes, due to begin in July, reflect wider shifts...
Read Article -
Blog articles 06.06.19
Blinded by the light (Guest Blog)
A first step towards trust could be a transparent conversation about the principles we as stakeholders have in common. The EFPIA Oncology Platform sees...
Read Article -
Blog articles 05.06.19
Connecting healthcare across the industry and stakeholders to implement the 3Rs
Since the adoption of the EU legislation governing animal use, EFPIA and its members have been publishing reports to visibly highlight our actions on putting...
Read Article -
Blog articles 29.05.19
R&D: Why the EU bank invests in (patented) ideas (Guest blog)
A favourable IP environment is essential to compensate for the disadvantages that life sciences companies face when seeking investor support. Without this...
Read Article -
Blog articles 29.05.19
‘Three more months is a lot if you have six months to live’ (Guest blog)
Bettina Ryll, a medically-trained scientist, started the Melanoma Patient Network Europe after her husband died of the disease. She knows the value of...
Read Article -
Statements & press releases 23.05.19
From votes to vision
The health of the EU’s citizens depends on all of us - policy-makers, healthcare professionals, civil society and industry. Pooling our resources and expertise...
Read Article -
Blog articles 23.05.19
Cancer medicines: Why we must strengthen the link between price and value (Guest blog)
A WHO Technical Report on pricing of cancer medicines has raised questions for its unorthodox view of value-based pricing. The report is critical of what...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 06.02.19
Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver
For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in future. We are deeply concerned that...
Read Article -
EFPIA News 26.09.18
The Value of Health: Improving Outcomes
More effective, patient-centred, and sustainable health systems: the benefits of health outcomes measurement
Read Article -
EFPIA News 07.08.18
Exploring the science and innovation behind #WeWontRest
A new partnership with ITN Productions
Read Article -
EFPIA News 26.06.18
Video and report of the Unlocking Tomorrow’s Cures Exhibition, 22-25 May 2018, European Parliament
The exhibition explored the cutting-edge science behind new treatments and how it is transforming patients’ lives.
Read Article -
EFPIA News 25.06.18
Apply now for the Health Collaboration Awards 2018
Submit a project by 21 September 2018
Read Article -
EFPIA News 08.05.18
EFPIA position on proposal for a Regulation of the European Parliament and the Council on HTA and amending...
This paper outlines EFPIA’s views on the four pillars of EU HTA cooperation included in the Commission proposal
Read Article -
EFPIA News 03.05.18
Early Career Research Prize in Vaccinology R&D – 2nd edition
Promote and foster a younger generation of scientists in the early stages of their career!
Read Article -
EFPIA News 03.07.17
EFPIA-College of Europe Prize
The 2017 Laureat of the EFPIA-College of Europe Prize is Luca Deplano
Read Article -
EFPIA News 30.05.17
Final Call ATMP Survey
Help improve product development and regulation
Read Article -
EFPIA News 24.04.17
Open Letter from the Pharmaceutical Industry Heads of Research and EFPIA on the Relocation of the European...
Read Article -
EFPIA News 19.04.17
EPAA Refinement Prize 2017
Call for Submissions
Read Article -
EFPIA News 31.03.17
Open Invitation for ATMP-developers
To help improve product development and its regulation
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 11.06.19
Road to Value Based Healthcare
A full-day seminar in Warsaw on the role of outcomes-measurement in delivering more for patients and improving the long-term sustainability of our health...
Read Article -
Statements & press releases 23.05.19
From votes to vision
The health of the EU’s citizens depends on all of us - policy-makers, healthcare professionals, civil society and industry. Pooling our resources and expertise...
Read Article -
Statements & press releases 08.05.19
EFPIA and CPIA Joint China/EU Pharmaceutical Industry Forum to Explore New Frontiers in Pharmaceutical...
The workshop covers 4 different themes: Pharmaceuticals in the Environment, Pricing & Reimbursement, Compliance (marketing ethics) and NMPA in the ICH
Read Article -
Statements & press releases 17.04.19
Health industries welcome unprecedented progress leading to an adoption of Horizon Europe, its areas...
The text agreed allows our sectors to remain ambitious about a healthier future for European citizens, based on medical innovation, timely access to quality...
Read Article -
Statements & press releases 17.04.19
Redressing Europe’s innovation balance
As the waiver will hit innovation in Europe, the research-based industry stands ready to work with policy makers across Europe to see how we can restore...
Read Article -
Statements & press releases 09.04.19
European Semester: Country Reports 2019
The reports show that several EU countries to not invest enough in healthcare, and that all countries have needs for further reform, notably in terms of...
Read Article -
Statements & press releases 19.03.19
Bold vision needed to translate basic health research in to new ways of delivering healthcare and new...
BioMed Alliance and EFPIA have teamed up to address the gaps within the translational research ecosystem and call for more focus and funding for translational...
Read Article -
Statements & press releases 12.03.19
Joint Press Statement of the Inter Associations Initiative Pharmaceuticals in the Environment Task Force...
Minimising the impact of medicines on the environment while safeguarding access to effective treatments for patients is a critical issue across all sectors...
Read Article -
Statements & press releases 20.02.19
Heading towards value-based healthcare
How measuring outcomes leads to better patients’ health and sustainable health systems
Read Article -
Statements & press releases 14.02.19
Europe’s gamble with the future of medical innovation
EFPIA notes the gamble on Europe’s future in medical innovation taken by the EU institutions in today’s trilogue meeting on the SPC manufacturing waiver...
Read Article -
Statements & press releases 08.02.19
Medicines verification system goes live across EU to better protect patients from falsified medicines...
The new system is a world-first for its stakeholder model, its scale, its use of new technologies and represents an unprecedented step towards preventing...
Read Article -
Statements & press releases 23.01.19
Europe’s economic and Intellectual Property Crossroads
We are at a crossroads between a future based on science, innovation and access for patients to cutting edge treatments or a future where European patients...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 14.06.19
Rare & childhood diseases: addressing unmet need
With the right framework in place we can continue to work together to meet the needs of children and adults living with a rare disease. As an industry...
Read Article -
Blog articles 13.06.19
Can registries drive better outcomes for diabetes patients? (Guest blog)
A roundtable in Stockholm will explore the opportunities and barriers to diabetes registries
Read Article -
Blog articles 12.06.19
Cancer data: Are you ready to meet your DigiTwin? (Guest blog)
Predictive computer models will guide clinical decisions, helping clinicians choose the most effective prevention and treatment options for you
Read Article -
Blog articles 11.06.19
Making the connections that count: building bridges to the future
With the challenges facing healthcare in Europe I am pretty certain no one sector has all the answers. It is vital that we come together to explore the...
Read Article -
Blog articles 06.06.19
Rethinking access to medicines in Lithuania (Guest blog)
Lithuania is on the cusp of a major overhaul of its Health Technology Assessment (HTA) system. The changes, due to begin in July, reflect wider shifts...
Read Article -
Blog articles 06.06.19
Blinded by the light (Guest Blog)
A first step towards trust could be a transparent conversation about the principles we as stakeholders have in common. The EFPIA Oncology Platform sees...
Read Article -
Blog articles 05.06.19
Connecting healthcare across the industry and stakeholders to implement the 3Rs
Since the adoption of the EU legislation governing animal use, EFPIA and its members have been publishing reports to visibly highlight our actions on putting...
Read Article -
Blog articles 29.05.19
R&D: Why the EU bank invests in (patented) ideas (Guest blog)
A favourable IP environment is essential to compensate for the disadvantages that life sciences companies face when seeking investor support. Without this...
Read Article -
Blog articles 29.05.19
‘Three more months is a lot if you have six months to live’ (Guest blog)
Bettina Ryll, a medically-trained scientist, started the Melanoma Patient Network Europe after her husband died of the disease. She knows the value of...
Read Article -
Blog articles 23.05.19
Cancer medicines: Why we must strengthen the link between price and value (Guest blog)
A WHO Technical Report on pricing of cancer medicines has raised questions for its unorthodox view of value-based pricing. The report is critical of what...
Read Article -
Blog articles 23.05.19
Gene therapy for liver disease: The power of protecting new ideas (Guest blog)
The IP environment in Europe has helped companies like Vivet turn ideas into assets that create value, jobs and address unmet medical need. This in turn...
Read Article -
Blog articles 16.05.19
Why a pharma investor quit his day job to follow a vision (Guest blog)
Dr Riad Sherif, CEO of Oculis, emphasises the importance of IP protection to attract investments in developing innovative medicines and treatments for...
Read Article